|
시장보고서
상품코드
2152402
인간 개인 식별 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 용도별, 기술별, 최종사용자별, 지역별 및 부문별 전망(2026-2033년)Human Identification Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Application (Forensics, Paternity Testing), By Technology, By End User, By Region, And Segment Forecasts, 2026 - 2033 |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
인간 개인 식별 시장 요약
세계의 인간 개인 식별 시장 규모는 2025년에 8억 4,570만 달러로 평가되며, 2026년 9억 2,780만 달러에서 2033년까지 18억 7,320만 달러로 성장할 것으로 예상되며, 2026-2033년의 연평균 성장률(CAGR)은 10.6%에 달할 것으로 전망됩니다.
북미가 시장을 주도하고 있으며, 2025년에는 38.0%라는 가장 큰 매출 점유율을 차지했습니다. 시장의 성장은 법의학 수사, DNA 프로파일링, 친자 확인, 실종자 신원 확인에 대한 수요 증가 및 분자 식별 기술의 발전에 의해 주도되고 있습니다.
목차
제1장 조사 방법 및 범위
제2장 요약
제3장 시장: 변수, 동향, 범위
- 시장 계보 전망
- 시장 역학
- 업계 분석 툴
제4장 제품별 비즈니스 분석
- 개인 식별 시장: 제품별 동향 분석
- 소모품
- 기기
- 소프트웨어
제5장 기술별 비즈니스 분석
- 개인 식별 시장: 기술별 동향 분석
- 중합효소 연쇄 반응(PCR)
- 모세관 전기영동(CE)
- 차세대 염기서열 분석(NGS)
- 마이크로어레이
- 신속 DNA 분석
제6장 용도별 비즈니스 분석
- 인간 개인 식별 시장: 용도별 동향 분석
- 법의학
- 친자감정
- 기타 용도
제7장 최종사용자별 비즈니스 분석
- 인간 개인 식별 시장: 최종사용자별 동향 분석
- 법과학연구소
- 연구 센터 및 학술·정부 기관
- 기타 최종사용자
제8장 지역별 비즈니스 분석
- 개인 식별 시장 점유율: 지역별, 2025-2033년
- 북미
- 북미 개인 식별 시장, 2021년?2033년
- 미국
- 캐나다
- 멕시코
- 유럽
- 유럽의 인간 개인 식별 시장, 2021-2033년
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
- 아시아태평양
- 아시아태평양 개인 식별 시장, 2021-2033년
- 일본
- 중국
- 인도
- 호주
- 태국
- 한국
- 라틴아메리카
- 라틴아메리카 개인 식별 시장, 2021년?2033년
- 브라질
- 아르헨티나
- 중동 및 아프리카
- MEA의 개인 식별 시장, 2021-2033년
- 남아프리카
- 사우디아라비아
- UAE
- 쿠웨이트
제9장 경쟁 현황
- 기업 분류
- 기업 점유율 및 포지셔닝 분석, 2025년
- 전략 매핑
- 기업 개요 및 리스트
- Thermo Fisher Scientific Inc.
- QIAGEN
- Promega Corporation
- Hamilton Company
- ANDE Corporation
- AutoGen, Inc.
- INNOGENOMICS TECHNOLOGIES, LLC.
- FUJIFILM Wako Pure Chemical Corporation（a subsidiary of FUJIFILM Corporation）
- MACHEREY-NAGEL GmbH & Co. KG
- BIOTYPE GmbH
Human Identification Market Summary
The global human identification market size was valued at USD 845.7 million in 2025 and is projected to grow from USD 927.8 million in 2026 to USD 1,873.2 million by 2033, at a CAGR of 10.6% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 38.0% in 2025. Market growth is driven by increasing demand for forensic investigations, DNA profiling, paternity testing, missing-person identification, and advancements in molecular identification technologies.
Global Human Identification Market Report Segmentation
This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global human identification market report based on product, technology, application, end user, and region:
- Product Outlook (Revenue, USD Million, 2021 - 2033)
- Consumables
- Instruments
- Software
- Technology Outlook (Revenue, USD Million, 2021 - 2033)
- Polymerase Chain Reaction (PCR)
- Capillary Electrophoresis (CE)
- Next-Generation Sequencing (NGS)
- Microarrays
- Rapid DNA Analysis
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Forensics
- Paternity Testing
- Other Applications
- End User Outlook (Revenue, USD Million, 2021 - 2033)
- Forensic Laboratories
- Research Centers and Academic & Government Institutes
- Other End Users
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Brazil
- Argentina
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.1.1. Segment Definitions
- 1.1.1.1. Product Segment
- 1.1.1.2. Technology Segment
- 1.1.1.3. Application Segment
- 1.1.1.4. End User Segment
- 1.1.1. Segment Definitions
- 1.2. Regional Scope
- 1.3. Estimates and Forecast Timeline
- 1.4. Objectives
- 1.5. Research Methodology
- 1.6. Information Procurement
- 1.6.1. Purchased Database
- 1.6.2. GVR's Internal Database
- 1.6.3. Secondary Sources
- 1.6.4. Primary Research
- 1.7. Information or Data Analysis:
- 1.7.1. Data Analysis Models
- 1.8. Market Formulation & Validation
- 1.9. Model Details
- 1.9.1. Commodity Flow Analysis
- 1.9.2. List of Secondary Sources
- 1.9.3. List of Abbreviations
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing Adoption of DNA Profiling
- 3.2.1.2. Rising Crime and Forensic Investigations
- 3.2.1.3. Expansion of Forensic Databases
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Complexity of DNA Sample Processing and Analysis
- 3.2.2.2. High Cost of Advanced Forensic Identification Systems
- 3.2.3. Market Opportunities Analysis
- 3.2.4. Market Challenges Analysis
- 3.2.1. Market Driver Analysis
- 3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTLE Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Economic landscape
- 3.3.2.5. Legal landscape
- 3.3.1. Porter's Five Forces Analysis
Chapter 4. Product Business Analysis
- 4.1. Segment Dashboard
- 4.2. Human Identification Market: Product Movement Analysis
- 4.3. Consumables
- 4.3.1. Consumables Market, 2021 - 2033 (USD Million)
- 4.4. Instruments
- 4.4.1. Instruments Market, 2021 - 2033 (USD Million)
- 4.5. Software
- 4.5.1. Software Market, 2021 - 2033 (USD Million)
Chapter 5. Technology Business Analysis
- 5.1. Segment Dashboard
- 5.2. Human Identification Market: Technology Movement Analysis
- 5.3. Polymerase Chain Reaction (PCR)
- 5.3.1. Polymerase Chain Reaction (PCR) Market, 2021 - 2033 (USD Million)
- 5.4. Capillary Electrophoresis (CE)
- 5.4.1. Capillary Electrophoresis (CE) Market, 2021 - 2033 (USD Million)
- 5.5. Next-Generation Sequencing (NGS)
- 5.5.1. Next-Generation Sequencing (NGS) Market, 2021 - 2033 (USD Million)
- 5.6. Microarrays
- 5.6.1. Microarrays Market, 2021 - 2033 (USD Million)
- 5.7. Rapid DNA Analysis
- 5.7.1. Rapid DNA Analysis Market, 2021 - 2033 (USD Million)
Chapter 6. Application Business Analysis
- 6.1. Segment Dashboard
- 6.2. Human Identification Market: Application Movement Analysis
- 6.3. Forensics
- 6.3.1. Forensics Market, 2021 - 2033 (USD Million)
- 6.4. Paternity Testing
- 6.4.1. Paternity Testing Market, 2021 - 2033 (USD Million)
- 6.5. Other Applications
- 6.5.1. Other Applications Market, 2021 - 2033 (USD Million)
Chapter 7. End User Business Analysis
- 7.1. Segment Dashboard
- 7.2. Human Identification Market: End User Movement Analysis
- 7.3. Forensic Laboratories
- 7.3.1. Forensic Laboratories Market, 2021 - 2033 (USD Million)
- 7.4. Research Centers and Academic & Government Institutes
- 7.4.1. Research Centers and Academic & Government Institutes Market, 2021 - 2033 (USD Million)
- 7.5. Other End Users
- 7.5.1. Other End Users Market, 2021 - 2033 (USD Million)
Chapter 8. Regional Business Analysis
- 8.1. Human Identification Market Share By Region, 2025 & 2033
- 8.2. North America
- 8.2.1. North America Human Identification Market, 2021 - 2033 (USD Million)
- 8.2.2. U.S.
- 8.2.2.1. Key Country Dynamics
- 8.2.2.2. Competitive Scenario
- 8.2.2.3. Regulatory Framework
- 8.2.2.4. U.S. Human Identification Market, 2021 - 2033 (USD Million)
- 8.2.3. Canada
- 8.2.3.1. Key Country Dynamics
- 8.2.3.2. Competitive Scenario
- 8.2.3.3. Regulatory Framework
- 8.2.3.4. Canada Human Identification Market, 2021 - 2033 (USD Million)
- 8.2.4. Mexico
- 8.2.4.1. Key Country Dynamics
- 8.2.4.2. Competitive Scenario
- 8.2.4.3. Regulatory Framework
- 8.2.4.4. Mexico Human Identification Market, 2021 - 2033 (USD Million)
- 8.3. Europe
- 8.3.1. Europe Human Identification Market, 2021 - 2033 (USD Million)
- 8.3.2. UK
- 8.3.2.1. Key Country Dynamics
- 8.3.2.2. Competitive Scenario
- 8.3.2.3. Regulatory Framework
- 8.3.2.4. UK Human Identification Market, 2021 - 2033 (USD Million)
- 8.3.3. Germany
- 8.3.3.1. Key Country Dynamics
- 8.3.3.2. Competitive Scenario
- 8.3.3.3. Regulatory Framework
- 8.3.3.4. Germany Human Identification Market, 2021 - 2033 (USD Million)
- 8.3.4. France
- 8.3.4.1. Key Country Dynamics
- 8.3.4.2. Competitive Scenario
- 8.3.4.3. Regulatory Framework
- 8.3.4.4. France Human Identification Market, 2021 - 2033 (USD Million)
- 8.3.5. Italy
- 8.3.5.1. Key Country Dynamics
- 8.3.5.2. Competitive Scenario
- 8.3.5.3. Regulatory Framework
- 8.3.5.4. Italy Human Identification Market, 2021 - 2033 (USD Million)
- 8.3.6. Spain
- 8.3.6.1. Key Country Dynamics
- 8.3.6.2. Competitive Scenario
- 8.3.6.3. Regulatory Framework
- 8.3.6.4. Spain Human Identification Market, 2021 - 2033 (USD Million)
- 8.3.7. Denmark
- 8.3.7.1. Key Country Dynamics
- 8.3.7.2. Competitive Scenario
- 8.3.7.3. Regulatory Framework
- 8.3.7.4. Denmark Human Identification Market, 2021 - 2033 (USD Million)
- 8.3.8. Sweden
- 8.3.8.1. Key Country Dynamics
- 8.3.8.2. Competitive Scenario
- 8.3.8.3. Regulatory Framework
- 8.3.8.4. Sweden Human Identification Market, 2021 - 2033 (USD Million)
- 8.3.9. Norway
- 8.3.9.1. Key Country Dynamics
- 8.3.9.2. Competitive Scenario
- 8.3.9.3. Regulatory Framework
- 8.3.9.4. Norway Human Identification Market, 2021 - 2033 (USD Million)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific Human Identification Market, 2021 - 2033 (USD Million)
- 8.4.2. Japan
- 8.4.2.1. Key Country Dynamics
- 8.4.2.2. Competitive Scenario
- 8.4.2.3. Regulatory Framework
- 8.4.2.4. Japan Human Identification Market, 2021 - 2033 (USD Million)
- 8.4.3. China
- 8.4.3.1. Key Country Dynamics
- 8.4.3.2. Competitive Scenario
- 8.4.3.3. Regulatory Framework
- 8.4.3.4. China Human Identification Market, 2021 - 2033 (USD Million)
- 8.4.4. India
- 8.4.4.1. Key Country Dynamics
- 8.4.4.2. Competitive Scenario
- 8.4.4.3. Regulatory Framework
- 8.4.4.4. India Human Identification Market, 2021 - 2033 (USD Million)
- 8.4.5. Australia
- 8.4.5.1. Key Country Dynamics
- 8.4.5.2. Competitive Scenario
- 8.4.5.3. Regulatory Framework
- 8.4.5.4. Australia Human Identification Market, 2021 - 2033 (USD Million)
- 8.4.6. Thailand
- 8.4.6.1. Key Country Dynamics
- 8.4.6.2. Competitive Scenario
- 8.4.6.3. Regulatory Framework
- 8.4.6.4. Thailand Human Identification Market, 2021 - 2033 (USD Million)
- 8.4.7. South Korea
- 8.4.7.1. Key Country Dynamics
- 8.4.7.2. Competitive Scenario
- 8.4.7.3. Regulatory Framework
- 8.4.7.4. South Korea Human Identification Market, 2021 - 2033 (USD Million)
- 8.5. Latin America
- 8.5.1. Latin America Human Identification Market, 2021 - 2033 (USD Million)
- 8.5.2. Brazil
- 8.5.2.1. Key Country Dynamics
- 8.5.2.2. Competitive Scenario
- 8.5.2.3. Regulatory Framework
- 8.5.2.4. Brazil Human Identification Market, 2021 - 2033 (USD Million)
- 8.5.3. Argentina
- 8.5.3.1. Key Country Dynamics
- 8.5.3.2. Competitive Scenario
- 8.5.3.3. Regulatory Framework
- 8.5.3.4. Argentina Human Identification Market, 2021 - 2033 (USD Million)
- 8.6. MEA
- 8.6.1. MEA Human Identification Market, 2021 - 2033 (USD Million)
- 8.6.2. South Africa
- 8.6.2.1. Key Country Dynamics
- 8.6.2.2. Competitive Scenario
- 8.6.2.3. Regulatory Framework
- 8.6.2.4. South Africa Human Identification Market, 2021 - 2033 (USD Million)
- 8.6.3. Saudi Arabia
- 8.6.3.1. Key Country Dynamics
- 8.6.3.2. Competitive Scenario
- 8.6.3.3. Regulatory Framework
- 8.6.3.4. Saudi Arabia Human Identification Market, 2021 - 2033 (USD Million)
- 8.6.4. UAE
- 8.6.4.1. Key Country Dynamics
- 8.6.4.2. Competitive Scenario
- 8.6.4.3. Regulatory Framework
- 8.6.4.4. UAE Human Identification Market, 2021 - 2033 (USD Million)
- 8.6.5. Kuwait
- 8.6.5.1. Key Country Dynamics
- 8.6.5.2. Competitive Scenario
- 8.6.5.3. Regulatory Framework
- 8.6.5.4. Kuwait Human Identification Market, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Company Categorization
- 9.2. Company Market Share/ Position Analysis, 2025
- 9.3. Strategy Mapping
- 9.4. Company Profiles/Listing
- 9.4.1. Thermo Fisher Scientific Inc.
- 9.4.1.1. Overview
- 9.4.1.2. Financial Performance
- 9.4.1.3. Product Benchmarking
- 9.4.1.4. Strategic Initiatives
- 9.4.2. QIAGEN
- 9.4.2.1. Overview
- 9.4.2.2. Financial Performance
- 9.4.2.3. Product Benchmarking
- 9.4.2.4. Strategic Initiatives
- 9.4.3. Promega Corporation
- 9.4.3.1. Overview
- 9.4.3.2. Financial Performance
- 9.4.3.3. Product Benchmarking
- 9.4.3.4. Strategic Initiatives
- 9.4.4. Hamilton Company
- 9.4.4.1. Overview
- 9.4.4.2. Financial Performance
- 9.4.4.3. Product Benchmarking
- 9.4.4.4. Strategic Initiatives
- 9.4.5. ANDE Corporation
- 9.4.5.1. Overview
- 9.4.5.2. Financial Performance
- 9.4.5.3. Product Benchmarking
- 9.4.5.4. Strategic Initiatives
- 9.4.6. AutoGen, Inc.
- 9.4.6.1. Overview
- 9.4.6.2. Financial Performance
- 9.4.6.3. Product Benchmarking
- 9.4.6.4. Strategic Initiatives
- 9.4.7. INNOGENOMICS TECHNOLOGIES, LLC.
- 9.4.7.1. Overview
- 9.4.7.2. Financial Performance
- 9.4.7.3. Product Benchmarking
- 9.4.7.4. Strategic Initiatives
- 9.4.8. FUJIFILM Wako Pure Chemical Corporation (a subsidiary of FUJIFILM Corporation)
- 9.4.8.1. Overview
- 9.4.8.2. Financial Performance
- 9.4.8.3. Product Benchmarking
- 9.4.8.4. Strategic Initiatives
- 9.4.9. MACHEREY-NAGEL GmbH & Co. KG
- 9.4.9.1. Overview
- 9.4.9.2. Financial Performance
- 9.4.9.3. Product Benchmarking
- 9.4.9.4. Strategic Initiatives
- 9.4.10. BIOTYPE GmbH
- 9.4.10.1. Overview
- 9.4.10.2. Financial Performance
- 9.4.10.3. Product Benchmarking
- 9.4.10.4. Strategic Initiatives
- 9.4.1. Thermo Fisher Scientific Inc.
